Septic arthritis is a disease caused by a bacterial infection or invasion in the joints leading to inflammation. Symptoms of septic arthritis include redness, heat, and pain in the joints reducing their movement. It is caused by bacteria, viruses, fungi, and parasites. Diabetes, osteoarthritis, gout, rheumatoid arthritis, joint trauma and poor immune function are major risk factors for septic arthritis.
America is the largest market for septic arthritis owing to the rising prevalence of septic arthritis in the U.S., According to the Center for Disease Control and Prevention, an estimated 78 million (26%) U.S. adults aged 18 years or older are projected to have doctor-diagnosed arthritis by 2040. Furthermore, arthritis prevalence was the highest among people 65 years and older, women, and obese population.
Europe is the second largest market for septic arthritis owing to the rising prevalence of rheumatoid arthritis in European countries and availability of funds for research and development activities.
In 2018, the global Septic Arthritis market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Septic Arthritis status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Septic Arthritis development in United States, Europe and China.

The key players covered in this study
Lupin Pharmaceuticals, Inc. (U.S.)
F. Hoffmann-La Roche Ltd (Swtizerland)
AbbVie Inc. (U.S.)
Amgen Inc. (U.S.)
Bristol-Myers Squibb Company (U.S.)
Johnson & Johnson Inc. (U.S.)
Pfizer (U.S.)
...

Market segment by Type, the product can be split into
Diagnosis
Treatment

Market segment by Application, split into
Orthopedic Hospitals
Clinics
Diagnostic Centers

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Septic Arthritis status, future forecast, growth opportunity, key market and key players.
To present the Septic Arthritis development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Septic Arthritis are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.